Chronic Myelomonocytic Leukemia-0
1 clinical trials · Condition
◉ Watch Chronic Myelomonocytic Leukemia-0
| Record | Firm | Date |
|---|---|---|
| Seclidemstat and Azacitidine for the Treatment of Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT04734990) | M.D. Anderson Cancer Center | 2021-07-07 |
Track Chronic Myelomonocytic Leukemia-0 automatically
Every clearance here is in the API, with alerts when new ones post.